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■ ORIGINAL ARTICLE ■
Introduction
Cervical cancer is an important female malignancy and
has been reported to be the third most common can-
cer affecting women [1]. Although cervical cancer is
not a sexually transmitted disease, it is related to the
presence of the human papillomavirus (HPV), which is
sexually transmitted [1]. About 500,000 cases of cervi-
cal cancer are registered every year worldwide, of which
an estimated 80% occur in developing countries [2].
The World Health Organization has estimated that 
7 million new cancer cases occur every year, at least half
of which are in low-income, developing countries [2].
The discovery of HPV as an etiologic agent for cervical
cancer has generated increased interest in the biology
and oncogenicity of this virus [3]. Birley [3] proposed
that HPV infection could be an important factor con-
tributing to the high prevalence of cervical carcinoma
in developing countries.
The HPV E7 protein can be detected predominantly
in the nucleus and, to a lesser extent, in the cytoplasm
in cells of the cervical cancer cell line, Ca Ski, in vitro,
and in invasive cervical carcinoma in situ, suggesting
that nuclear E7 plays a major role in cervical carcino-
genesis in humans [4]. HPV E7 has been reported to
be functionally associated with the tumor suppressor
interferon regulatory factor (IRF)-1 in cervical carcino-
genesis [5]. Binding assays indicate a physical inter-
action between IRF-1 and HPV E7 in vivo and in vitro
[5]. Um et al [6] found that E7 transgene expression
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inactivated the transactivation function of IRF-1 in vivo,
which could be an important aspect of its role in can-
cer development. It is difficult to study the interaction
between these two proteins during carcinogenesis, but
new developments in bioinformatics can be applied to
nanoscale genomics and proteomics research. In this
study, a new gene ontology technology was used to
predict changes in the molecular function and biologic
processes caused by the interaction between IRF-1 and
HPV E7.
Materials and Methods
Determination of amino acid sequences for 
IRF-1 and HPV E7
The database PubMed was used for data mining to
access the amino acid sequences of IRF-1 and HPV E7.
Prediction of molecular function and biologic 
processes
A novel gene ontology prediction tool, GoFigure, was
used to predict the molecular function and biologic
process of IRF-1 and of the combination of IRF-1 and
HPV E7 (IRF-1-E7) [7]. GoFigure is a computational
algorithm tool which has been recently developed 
for gene ontology studies [7]. This tool accepts input
DNA or protein sequences and uses BLAST to identify
homologous sequences in gene ontology-annotated
databases. It is also possible to use a BLAST search to
identify homologs in public databases that have been
annotated with gene ontology terms, including SWISS-
PROT, FlyBase (Drosophila), the Saccharomyces Genome
Database (SGD), Mouse Genome Informatics (MGI),
and WormBase (nematode) [7]. Results for molecular
function, as well as for biologic processes of the studied
protein, can be predicted [7]. The predicted molecular
functions and biologic processes of IRF-1 and IRF-1-E7
were presented and compared in this study.
Results
The molecular function and biologic processes of 
IRF-1 and IRF-1-E7 are presented in Figures 1 and 2.
The molecular functions and biologic processes of
IRF-1 and the combination of IRF-1-E7 are compared
in the Table.
Discussion
A strong association between cervical cancer and high-
risk HPV-16 and -18 infections underlines the impor-
tance of the virus in the pathogenesis of many squamous
cell carcinomas [8]. High-risk HPV infection can lead to
carcinogenesis and tumor progression, predominantly
through the actions of the viral oncogene, E7 [8]. Con-
stitutive activation of the telomerase is a key step in the
development of human cancers [9]. Interferon (IFN)-γ
signaling induces growth arrest in many tumors through
multiple regulatory mechanisms. Lee et al [9] noted that
IFN-γ signaling repressed telomerase activity and human
telomerase reverse transcriptase transcription, and sug-
gested that this signaling was mediated by IRF-1. They
also observed less telomerase repression in HPV E7-
negative, p53-mutant HT-3 cells, compared with HPV-
18 E6- and E7-positive HeLa cells [9]. Park et al [5]
suggested that HPV E7 interfered with the transactiva-
tion function of IRF-1 by recruiting histone deacetylase
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Figure 1. Expected molecular function of interferon regulatory factor-1.
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to the promoter, and they proposed that the inter-
action between IRF-1 and HPV E7 was important for
carcinogenesis.
Based on recent advances in genomic technology,
current microarray techniques can be used to analyze
the gene expression patterns of tens of thousands of
genes [7]. Gene ontology has been developed for this
specific purpose, and many gene ontology tools have
been constructed and launched. In this study, a gene
ontology tool was used to predict the functions of 
IRF-1 and IRF-1-E7. Compared with IRF-1, IRF-1-E7
uncovered many different functions and biologic pro-
cesses, including the positive regulation of many inter-
leukins. Kyo et al [10] proposed that inflammatory
cytokines contribute to the host’s defense against HPV
infection. However, Iglesias et al [11] found that HPV
E7 RNA expression and apoptosis increased in parallel
in proliferating keratinocytes in severe dysplasias and
carcinomas, suggesting that interleukin release was as-
sociated with progression to high-grade disease. They
also noted that high-level expression of the HPV E7
protein sensitized keratinocytes to apoptosis, resulting
in release of interleukins, multifunctional cytokines that
promote inflammation, tissue remodeling and epithelial
hyperplasia [11].
Interestingly, IRF-1-E7 also appeared to be involved
in the differentiation of T-helper cells in this study.
According to a recent study, disease recurrence was
accompanied by an increase in the total number of
specific short-term T-cell lines at follow-up, whereas
absence of disease was accompanied by a decrease in
specific short-term T-cell lines [12]. In addition, HPV-
specific memory cytotoxic T-cell (non-T-helper cell) pre-
cursors were detected, predominantly in women with
high-grade lesions or invasive cervical carcinomas, and
not in women who were completely clear of the virus.
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Figure 2. Expected molecular function of the combined interferon regulatory factor-1 and human papillomavirus E7.
Table. Comparison of the molecular functions and biologic processes of interferon regulatory factor (IRF)-1 and the 
combined IRF-1 and HPV E7 (IRF-1-E7)
Proteins Molecular function Biologic process
IRF-1 DNA binding, transcription factor activity Positive regulation of transcription (DNA-dependent)
RNA polymerase II transcriptional factor activity Negative regulation of transcription from Pol II 
RNA polymerase II transcriptional factor activity promoter
(enhancer-binding) Positive regulation of interleukin-12 biosynthesis
IRF-1-E7 DNA binding Negative regulation of transcription from Pol II 
Transcription factor activity promoter
RNA polymerase II transcriptional factor activity Positive regulation of interleukin-13 biosynthesis
Transcription factor binding Positive regulation of interleukin-4 biosynthesis
Transcriptional activator activity Positive regulation of interleukin-12 biosynthesis
Positive regulation of interleukin-2 biosynthesis
Positive regulation of interleukin-10 biosynthesis
Regulation of T-helper cell differentiation
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Further studies are needed to clarify the role of IRF-1-E7
in the process of differentiation of T-helper cells.
Further experimental studies are needed to confirm
the role of RIF-1-E7. The findings of this study, how-
ever, not only support the results of previous studies 
of HPV and cervical carcinoma, but also provide new
insights into the interaction between RIF-1 and HPV
E7. There were some limitations to this work; because
of the nature of ontology studies in bioinformatics,
schematic figures and explanations were provided to
show the possible interaction between the two mole-
cules. However, further laboratory studies are needed
to provide detailed evidence for the actual nature of this
specific protein–protein interaction. An in vitro protein–
protein pull-down assay should be performed to deter-
mine the biologic reaction implied by the results of 
this ontology study.
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